TRV250 is a δ-opioid receptor (DOR) agonist which is under development for the treatment of migraine. It is taken orally. The drug shows high selectivity for the DOR over the μ- and κ-opioid receptors.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.